Progenics Pharmaceuticals Inc. (PGNX) Shares Bought by Los Angeles...


Los Angeles Capital Management & Equity Research Inc. increased its position in Progenics Pharmaceuticals Inc. by 457.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 88,980 shares of the biotechnology company's stock after acquiring an additional 73,010 shares during the period.



from Biotech News